Insufficient scRNA-seq data for expression of TFAP2D at single-cell level.
Insufficient scRNA-seq data for expression of TFAP2D at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| ovary | 27% | 0.95 | 48 / 180 | 0% | 0 | 0 / 430 |
| brain | 23% | 4.69 | 605 / 2642 | 1% | 0.03 | 5 / 705 |
| lung | 2% | 0.08 | 12 / 578 | 15% | 1.09 | 175 / 1155 |
| bladder | 10% | 0.24 | 2 / 21 | 2% | 0.27 | 9 / 504 |
| uterus | 9% | 0.61 | 16 / 170 | 0% | 0 | 0 / 459 |
| stomach | 3% | 0.09 | 9 / 359 | 2% | 0.03 | 6 / 286 |
| peripheral blood | 4% | 0.11 | 38 / 929 | 0% | 0 | 0 / 0 |
| spleen | 4% | 0.21 | 9 / 241 | 0% | 0 | 0 / 0 |
| blood vessel | 3% | 0.09 | 42 / 1335 | 0% | 0 | 0 / 0 |
| breast | 3% | 0.07 | 12 / 459 | 0% | 0.01 | 5 / 1118 |
| esophagus | 2% | 0.07 | 34 / 1445 | 1% | 0.01 | 1 / 183 |
| adipose | 3% | 0.08 | 32 / 1204 | 0% | 0 | 0 / 0 |
| adrenal gland | 1% | 0.02 | 3 / 258 | 1% | 0.04 | 3 / 230 |
| prostate | 2% | 0.07 | 6 / 245 | 0% | 0 | 0 / 502 |
| pancreas | 2% | 0.04 | 6 / 328 | 1% | 0.02 | 1 / 178 |
| intestine | 2% | 0.05 | 19 / 966 | 0% | 0.02 | 2 / 527 |
| muscle | 2% | 0.06 | 18 / 803 | 0% | 0 | 0 / 0 |
| heart | 2% | 0.06 | 19 / 861 | 0% | 0 | 0 / 0 |
| liver | 1% | 0.03 | 3 / 226 | 0% | 0.01 | 1 / 406 |
| thymus | 2% | 0.05 | 10 / 653 | 0% | 0 | 0 / 605 |
| kidney | 1% | 0.12 | 1 / 89 | 0% | 0.03 | 3 / 901 |
| skin | 1% | 0.02 | 18 / 1809 | 0% | 0 | 0 / 472 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0006366 | Biological process | transcription by RNA polymerase II |
| GO_0061379 | Biological process | inferior colliculus development |
| GO_0048856 | Biological process | anatomical structure development |
| GO_0043524 | Biological process | negative regulation of neuron apoptotic process |
| GO_0042127 | Biological process | regulation of cell population proliferation |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0000785 | Cellular component | chromatin |
| GO_0005667 | Cellular component | transcription regulator complex |
| GO_0005634 | Cellular component | nucleus |
| GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| Gene name | TFAP2D |
| Protein name | Transcription factor AP-2-delta (AP2-delta) (Activating enhancer-binding protein 2-delta) (Transcription factor AP-2-beta-like 1) |
| Synonyms | TFAP2BL1 |
| Description | FUNCTION: Sequence-specific DNA-binding protein that interacts with inducible viral and cellular enhancer elements to regulate transcription of selected genes. AP-2 factors bind to the consensus sequence 5'-GCCNNNGGC-3' and activate genes involved in a large spectrum of important biological functions including proper eye, face, body wall, limb and neural tube development. They also suppress a number of genes including MCAM/MUC18, C/EBP alpha and MYC (By similarity). . |
| Accessions | Q7Z6R9 ENST00000008391.4 |